AR028377A1 - Procedimiento para la preparacion de la sal mesilato trihidrato de 1-(4-hidroxifenil)-2-(4-hidroxi-4-fenilpiperidin-1-il)-1-propanol e intermedios utiles para dicha preparacion - Google Patents

Procedimiento para la preparacion de la sal mesilato trihidrato de 1-(4-hidroxifenil)-2-(4-hidroxi-4-fenilpiperidin-1-il)-1-propanol e intermedios utiles para dicha preparacion

Info

Publication number
AR028377A1
AR028377A1 ARP010101972A ARP010101972A AR028377A1 AR 028377 A1 AR028377 A1 AR 028377A1 AR P010101972 A ARP010101972 A AR P010101972A AR P010101972 A ARP010101972 A AR P010101972A AR 028377 A1 AR028377 A1 AR 028377A1
Authority
AR
Argentina
Prior art keywords
preparation
phenylpiperidin
hydroxyphenyl
propanol
hydroxy
Prior art date
Application number
ARP010101972A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR028377A1 publication Critical patent/AR028377A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/52Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ARP010101972A 2000-04-28 2001-04-26 Procedimiento para la preparacion de la sal mesilato trihidrato de 1-(4-hidroxifenil)-2-(4-hidroxi-4-fenilpiperidin-1-il)-1-propanol e intermedios utiles para dicha preparacion AR028377A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20041700P 2000-04-28 2000-04-28

Publications (1)

Publication Number Publication Date
AR028377A1 true AR028377A1 (es) 2003-05-07

Family

ID=22741639

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010101972A AR028377A1 (es) 2000-04-28 2001-04-26 Procedimiento para la preparacion de la sal mesilato trihidrato de 1-(4-hidroxifenil)-2-(4-hidroxi-4-fenilpiperidin-1-il)-1-propanol e intermedios utiles para dicha preparacion

Country Status (26)

Country Link
US (1) US6570018B2 (es)
EP (1) EP1149831B1 (es)
JP (1) JP2001354650A (es)
KR (1) KR100432841B1 (es)
CN (1) CN1211366C (es)
AR (1) AR028377A1 (es)
AT (1) ATE275130T1 (es)
AU (1) AU781715B2 (es)
BR (1) BR0101611A (es)
CA (1) CA2345286C (es)
CZ (1) CZ20011472A3 (es)
DE (1) DE60105221T2 (es)
DK (1) DK1149831T3 (es)
ES (1) ES2225425T3 (es)
HK (1) HK1040514B (es)
HU (1) HUP0101725A3 (es)
ID (1) ID30012A (es)
IL (1) IL142706A0 (es)
IN (1) IN191534B (es)
PL (1) PL347299A1 (es)
PT (1) PT1149831E (es)
RU (1) RU2192415C1 (es)
SI (1) SI1149831T1 (es)
TW (1) TWI222440B (es)
YU (1) YU27801A (es)
ZA (1) ZA200103321B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743921B2 (en) * 2002-01-24 2004-06-01 Dsm Catalytica Pharmaceuticals, Inc. Process for the preparation of nonracemic syn-1-(4-hydroxy-phenyl)-2-(4-hydroxy-4-phenyl-piperidin-1-yl)-1-propanol compounds
CN105037221B (zh) * 2015-06-18 2017-05-10 吉林大学珠海学院 一种具有神经保护作用的化合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1615861A (zh) 1995-08-11 2005-05-18 美国辉瑞有限公司 (1s,2s)-1-(4-羟基苯基)-2-(4-羟基-4-苯基哌啶-1-基)-1-丙醇甲磺酸盐三水合物
TW450807B (en) * 1995-09-15 2001-08-21 Pfizer Pharmaceutical compositions for treating tinnitus comprising neuroprotective agents

Also Published As

Publication number Publication date
YU27801A (sh) 2003-04-30
IN191534B (es) 2003-12-06
ATE275130T1 (de) 2004-09-15
AU3889701A (en) 2001-12-13
SI1149831T1 (en) 2005-02-28
ZA200103321B (en) 2002-10-24
CN1211366C (zh) 2005-07-20
DE60105221D1 (de) 2004-10-07
RU2192415C1 (ru) 2002-11-10
TWI222440B (en) 2004-10-21
HUP0101725A2 (hu) 2002-02-28
ID30012A (id) 2001-11-01
DE60105221T2 (de) 2005-09-15
CZ20011472A3 (cs) 2001-12-12
HUP0101725A3 (en) 2003-04-28
ES2225425T3 (es) 2005-03-16
CN1322716A (zh) 2001-11-21
PL347299A1 (en) 2001-11-05
CA2345286C (en) 2004-11-09
KR20010098924A (ko) 2001-11-08
EP1149831A1 (en) 2001-10-31
JP2001354650A (ja) 2001-12-25
EP1149831B1 (en) 2004-09-01
CA2345286A1 (en) 2001-10-28
KR100432841B1 (ko) 2004-05-24
AU781715B2 (en) 2005-06-09
HK1040514B (zh) 2005-10-28
HU0101725D0 (en) 2001-07-30
US6570018B2 (en) 2003-05-27
HK1040514A1 (en) 2002-06-14
IL142706A0 (en) 2002-03-10
US20020016466A1 (en) 2002-02-07
DK1149831T3 (da) 2004-12-06
PT1149831E (pt) 2004-11-30
BR0101611A (pt) 2002-01-15

Similar Documents

Publication Publication Date Title
DE60017449D1 (de) Dünn-bis-nass strukturen zur aufnahme von körperflüssigkeiten
PT1223927E (pt) Utilizacao de retigabina para o tratamento de dores neuropaticas
PT1392292E (pt) Piranoindazoles e sua utilizacao para o tratamento de glaucoma
ATE242599T1 (de) Fungizide co-formulierungen
PT1206436E (pt) Retinoides para o tratamento de enfisema
CL2004000652A1 (es) Uso de lactulosa para la inhibicion de infecciones por rotavirus de celulas animales o humanas.
AR028377A1 (es) Procedimiento para la preparacion de la sal mesilato trihidrato de 1-(4-hidroxifenil)-2-(4-hidroxi-4-fenilpiperidin-1-il)-1-propanol e intermedios utiles para dicha preparacion
PT1220858E (pt) Oxazinoquinolonas uteis para o tratamento de infeccoes virais
PT1268482E (pt) Piranoindois para o tratamento de glaucoma
AR027878A1 (es) Metodos para identificar y utilizar compuestos inhibidores de amiloides
HUP0101723A3 (en) Process for the preparation of the meylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol and intermediates useful therefor
ITMI981796A0 (it) Procedimento per la preparazione di r-(-)-carnitina
PT1200447E (pt) Oxazinocarbazoles para o tratamento de doencas do snc
BR9710712A (pt) N-metil-n-(4-(1h-benzimodazol-2-il)-¬1,4¾-diazepan-1-il)-2-(aril)-butil)benzamidas subastitu¡das Úteis para tratamento de doen-as al-rgicas
IT244314Y1 (it) Struttura perfezionata di barriera per la chiusura facilmenteamovibile di varchi.
PT1064014E (pt) Medicamento para o impedimento ou tratamento de tumores especificos de papilomavirus
AR028400A1 (es) Procedimiento para la preparacion de compuestos halogenados de hidroxidifenilo
AR028057A1 (es) Composicion y procedimiento para limpieza de pisos
AR026321A4 (es) Cuerpo para escobillon o cepillo
ES1043431Y (es) Escoba perfeccionada para la limpieza de suelos y rodapies.
ES1038965Y (es) Cabezal para mocho de fregona.
IT1307295B1 (it) Procedimento per la preparazione di filati ondee o compensina.
ITMI20000692A0 (it) Procedimento per il trattamento e il recupero di uova di animali
ITFI990247A0 (it) Procedimento per la realizzazione di materiali multiuso
ITMI990215V0 (it) Struttura per la pavimentazione di scuderie

Legal Events

Date Code Title Description
FB Suspension of granting procedure